Clinical Trial Update: Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating the biodistribution and dosimetry of Ga-68 P16-093 in prostate cancer (recurrent and broader prostate cancer indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ga-68 P16-093

Snippet

Sponsor: Five Eleven Pharma, Inc. | Conditions: Prostate Cancer Recurrent, Prostate Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING